Cite
MLA Citation
Sarah Injac et al.. “MBRS-56. SYSTEMATIC DRUG REPURPOSING IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES.” Neuro-oncology, vol. 20, no. 2, n.d., p. i140. http://access.bl.uk/ark:/81055/vdc_100095509579.0x000011